Nectar Life Sciences Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA113170
EBIT27113
Earning Per Share-31
Expenses1,4341,510
Net Profit-7325
Net Profit Margin-41
Operating Profit Margin69
Profit Before Tax-8534
Dividends Per Share00
Operation Revenue1,5471,680

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
20221,739.202,486.90993.609,042.131,441.20
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of Nectar Life Sciences is 170 as of 2/21/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020202023
Operating Activities65239285285134
Investing Activities-29-26-33-3352
Financing Activities-40-201-252-252-186
Others00000
Net Cash Flow-412-0-0-0

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2021-2.18-34.87-15.36-52.41
2023625.39-528.49-77.4619.45
20201,468.841,106.99-890.581,685.25
20235,887.50-4,137.30-2,686.10-935.90
20234,959.33-7,943.682,376.07-608.28
The cash flow from Operating Activities of Nectar Life Sciences is 134 as of 2/21/2024